skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

84 Total results for product and free and sample content found

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Oncology Market Leaders Maintain Their Upper Hand

14 Aug 2019

Drugs like Ibrance and Lynparza show that in the cancer market, it can be hard for new entrants to catch early standouts. 

Topic Drug development landscape Drug review

Biomedtracker: 開発中医薬品をFDA承認確率で評価

Biomedtracker Q3 2019 Outlook Report Extract

29 Jul 2019

In this report, we cover catalysts from 27 drugs, devices and diagnostics expected to occur in Q3 2019. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided. These data points were provided using a combination of Pharmapremia, Informa’s drug development benchmarking product utilizing Biomedtracker’s LOA data to assist in informed decisions about drug pipeline prioritization, partnerships, and acquisitions, and drug approval data from Biomedtracker.   

Topic drug-development-landscape drug-review research strategy

Meddevicetracker: 医療機器の市場調査分析・データベース

MeddeviceTracker Q3 2019 Outlook Report

24 Jul 2019

In this report, we cover catalysts from 27 drugs, devices and diagnostics expected to occur in Q3 2019. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided.

Topic strategy research drug-development-landscape drug-review

Datamonitor Healthcare: 医療用医薬品の市場調査レポート

Top 10 Best Selling Drugs of 2018 Fund US and EU Pharma RD

15 Jul 2019

Our latest whitepaper lists the top selling drugs last year, who developed them and the strategies behind their success. We drew from three of our top products to create our most recent whitepaper, Datamonitor Health Care, Biomedtracker and Pharmaprojects. You can experience them all for yourself. 

Topic Drug review Strategy Deal trends

Cannabidiol - HBW Insight coverage

10 Jul 2019

Cannabidiol (CBD) is being looked at more and more by health beauty and wellness companies for new OTC drugs, cosmetics and supplements. It is highly controversial because while CBD has many natural benefits for treating a variety of symptoms and conditions, it is the active ingredient in cannabis which comes from the hemp plant.

Topic drug-review drug-approval

Pink Sheet: 世界の薬事規制と承認審査に関するニュース

US Initiative To End HIV Epidemic Will Boost PrEP Access

03 Jul 2019

'Number of different initiatives' coming in next several months to make drugs more affordable, including for PrEP prophylaxis, HHS Assistant Secretary for Health Giroir says. Multi-agency approach is key strategy.

Topic drug-approval drug-development-landscape drug-review

Datamonitor Healthcare: 医療用医薬品の市場調査レポート

Understand Market Access Trends in the US, Europe and Emerging Markets

03 Jul 2019

This essential whitepaper looks at how increased drug spending and a rising desire for expenditure controls are influencing access dynamics across key markets. It is available to you now, for free.

Topic Drug development landscape Drug approval Drug review

Citeline

Taking the High Out of Pain: Exploring Abuse-Deterrent Opioids and Opioid Alternatives

03 Jul 2019

With opioid abuse and deaths in the US at an all-time high, the journey to battle the opioid epidemic continues – keeping drug companies and the FDA working hard to come up with effective alternatives for pain.

Topic drug-approval drug-review

お問い合わせ&レポートストア

専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

*一部のサービスでは無料トライアルをご利用になれません。

ご質問等ございましたらお気軽にご連絡下さい。

日本(平日:9時~18時)
電話:+81 (0)3 6273 4260
Email:inquiry.jp@informa.com

オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。